PATENT CLAIM ANALYSIS

Application Number: 16380513
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["705", "002000"]

Abstract:
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.

Claim (Index 4):
The method of  claim 3 , wherein the threshold is 35 or 50 ng/mL.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.35484
- Patent Class: 705.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15385095', '11789169', '13422574', '13787975', '15410155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.0969316397008065
- 35 USC 102 Novelty (BERT): 0.5821518065564134
- Combined Prediction Score: 0.1454536563863672
- Mean Citation Score: 292.468044
- Max Citation Score: 472.3801
- Similarity Product: 423.35737947528366

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test